Back to search
FDAFDA · Food and drugs·Recall number D-0389-2016

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01

Published December 9, 2015 · Recall initiated: August 21, 2015

Summary

FDA records drug Class II recall D-0389-2016, published December 9, 2015 and initiated August 21, 2015. Recalling firm: Nephron Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 32,490 cartons; Lot: Lots R4016A (Exp 08/31/2015), R4017A (Exp 08/31/2015), R4035A (Exp 12/31/2015). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nephron Pharmaceuticals Corp.
Distributor
Nationwide
Lot
Lots R4016A (Exp 08/31/2015), R4017A (Exp 08/31/2015), R4035A (Exp 12/31/2015)
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01 recalled?

Yes. FDA published recall D-0389-2016 on December 9, 2015. Reported hazard: Discoloration

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail